StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Medexus Pharmaceuticals Inc.
Toronto Stock Exchange:MDP.TO
Sector
Location
Market Cap
USD 64.56 M
Share Price
USD 2.00
Avg Daily Volume
38,563
Change (1 day)
-2.22%
Change (1 year)
21.65%
Change (YTD)
-16.76%
Medexus Pharmaceuticals Inc. Operating Income Margin for the year ending March 31, 2025: 7.59%
Medexus Pharmaceuticals Inc. Operating Income Margin is 7.59% for the year ending March 31, 2025, a -20.50% change year over year. Operating Income Ratio is the proportion of a company's operating income to its net sales, measuring the efficiency of its core business operations in generating profits.
-
Medexus Pharmaceuticals Inc. Operating Income Margin for the year ending March 31, 2024 was 9.55%, a 35.55% change year over year.
-
Medexus Pharmaceuticals Inc. Operating Income Margin for the year ending March 31, 2023 was 7.04%, a -136.03% change year over year.
-
Medexus Pharmaceuticals Inc. Operating Income Margin for the year ending March 31, 2022 was -19.55%, a 1,031.87% change year over year.
-
Medexus Pharmaceuticals Inc. Operating Income Margin for the year ending March 31, 2021 was -1.73%, a -83.27% change year over year.
Competitors
Eli Lilly and Company
USD 762.18
LLY
-9.53
-1.23%
AbbVie Inc.
USD 184.85
ABBV
-4.41
-2.33%
Roche Holding AG
USD 338.18
RO.SW
-2.81
-0.82%
AstraZeneca PLC
USD 138.01
AZN.L
-0.01
-0.01%
Merck & Co., Inc.
USD 79.31
MRK
-0.65
-0.81%
Amgen Inc.
USD 295.87
AMGN
+1.11
0.38%
Pfizer Inc.
USD 24.26
PFE
-0.21
-0.86%
Gilead Sciences, Inc.
USD 108.28
GILD
+0.06
0.06%
Sanofi
USD 96.20
SAN.PA
-0.42
-0.44%
Bristol-Myers Squibb Company
USD 46.69
BMY
-0.67
-1.42%
Chugai Pharmaceutical Co., Ltd.
USD 46.18
4519.T
-0.87
-1.84%
GSK plc
USD 18.13
GSK.L
+0.05
0.30%
Regeneron Pharmaceuticals, Inc.
USD 545.53
REGN
+3.01
0.56%
Cencora, Inc.
USD 292.67
COR
-0.20
-0.07%
Jiangsu Hengrui Medicine Co., Ltd.
USD 8.08
600276.SS
-0.10
-1.27%
Takeda Pharmaceutical Company Limited
USD 28.82
4502.T
-0.34
-1.16%
Haleon plc
USD 4.78
HLN.L
-0.03
-0.63%
Daiichi Sankyo Company, Limited
USD 23.75
4568.T
-0.42
-1.73%
Ucb S.A.
USD 202.58
UCB.BR
-0.69
-0.34%
BeOne Medicines Ltd.
USD 291.93
ONC
-2.62
-0.89%
Key Data
| Date | Operating Income Margin | Gross Profit Margin | EBIT Margin | EBITDA Margin |
|---|
Competitors
Eli Lilly and Company
USD 762.18
LLY
-9.53
-1.23%
AbbVie Inc.
USD 184.85
ABBV
-4.41
-2.33%
Roche Holding AG
USD 338.18
RO.SW
-2.81
-0.82%
AstraZeneca PLC
USD 138.01
AZN.L
-0.01
-0.01%
Merck & Co., Inc.
USD 79.31
MRK
-0.65
-0.81%
Amgen Inc.
USD 295.87
AMGN
+1.11
0.38%
Pfizer Inc.
USD 24.26
PFE
-0.21
-0.86%
Gilead Sciences, Inc.
USD 108.28
GILD
+0.06
0.06%
Sanofi
USD 96.20
SAN.PA
-0.42
-0.44%
Bristol-Myers Squibb Company
USD 46.69
BMY
-0.67
-1.42%
Chugai Pharmaceutical Co., Ltd.
USD 46.18
4519.T
-0.87
-1.84%
GSK plc
USD 18.13
GSK.L
+0.05
0.30%
Regeneron Pharmaceuticals, Inc.
USD 545.53
REGN
+3.01
0.56%
Cencora, Inc.
USD 292.67
COR
-0.20
-0.07%
Jiangsu Hengrui Medicine Co., Ltd.
USD 8.08
600276.SS
-0.10
-1.27%
Takeda Pharmaceutical Company Limited
USD 28.82
4502.T
-0.34
-1.16%
Haleon plc
USD 4.78
HLN.L
-0.03
-0.63%
Daiichi Sankyo Company, Limited
USD 23.75
4568.T
-0.42
-1.73%
Ucb S.A.
USD 202.58
UCB.BR
-0.69
-0.34%
BeOne Medicines Ltd.
USD 291.93
ONC
-2.62
-0.89%